Reduced neprilysin in high plaque areas of Alzheimer brain: a possible relationship to deficient degradation of β-amyloid peptide
Section snippets
Acknowledgements
This research was supported by a grants from the Jack Brown and Family A.D. Research Fund, as well as donations from The Friends of UBC and individual British Columbians.
References (10)
- et al.
Expression of constitutive nitric oxide synthase in rat and human gastrointestinal tract
Biochem. Biophys. Acta
(1999) - et al.
Molecular characterization of dendritically localized transcripts encoding MAP2
Mol. Brain Res.
(1996) - et al.
Novel low molecular weight microtubule-associated protein-2 isoforms contain a functional nuclear localization sequence
J. Biol. Chem.
(1999) - et al.
Aβ42-carboxy-terminal-like immunoreactivity is associated with intracellular neurofibrillary tangles and Pick bodies
Exp. Neurol.
(2000) - et al.
Upregulated production and activation of the complement system in Alzheimer's disease brain
Am. J. Pathol.
(1999)
There are more references available in the full text version of this article.
Cited by (319)
“Evaluation of neprilysin activity in Adipose-Derived stem cells from Alzheimer's disease patients”
2024, Neuroscience LettersAmyloid –β pathology in Alzheimer's disease: A nano delivery approach
2023, Vibrational SpectroscopyFuturistic aspect of nanocarriers on targeted delivery for dementia
2023, Nanomedicine-Based Approaches for the Treatment of DementiaThe three sisters of fate: Genetics, pathophysiology and outcomes of animal models of neurodegenerative diseases
2022, Neuroscience and Biobehavioral ReviewsStructural significance of Neprylysin from Streptococcus suis GZ1 in the degradation of Aβ peptides, a causative agent in Alzheimer's disease
2021, Computers in Biology and MedicineHypothesis: Intravenous administration of mesenchymal stem cells is effective in the treatment of Alzheimer's disease
2021, Medical HypothesesCitation Excerpt :Neprilysin regulates amyloid-β peptide levels [9]. Neprilysin activity is reduced in the brains of Alzheimer's patients, especially in areas where amyloid is deposited [10]. Mesenchymal stem cells administered intravenously through a drip can be used to regenerate the brain.
Copyright © 2001 Elsevier Science Ireland Ltd. All rights reserved.